Calcifediol Market - Strategic Insights and Forecasts (2026-2031)

Calcifediol Market Size:

The Global Calcifediol market is forecast to grow at a CAGR of 5.9%, reaching USD 2.8 billion in 2031 from USD 2.1 billion in 2026.

Calcifediol is a form of Vitamin D, also known as 25-hydroxyvitamin D3, produced by the liver by the process of hydroxylation of Vitamin D3 that we get from sunlight or diet. It is further hydroxylated in the kidney to form Calcitriol, an active form of vitamin D3.

Calcifediol in capsule or liquid dosage treats vitamin D deficiency or insufficiency, refractory rickets, familial hypophosphatemia, and secondary hypoparathyroidism. It is used to treat hypocalcemia and renal osteodystrophy in patients suffering from chronic renal failure. It is used with calcium to prevent osteoporosis. It is also used in animal feed to improve its vitamin D level and feed conversation ratio by improving the overall quality of livestock and poultry.

The rising demand for calcifediol is attributed to its more advantageous features than the other forms of vitamin D. Calcifediol is 3 times more potent than cholecalciferol, commonly used to treat vitamin D deficiency. At the same time, its absorption rate is higher than that of other forms of vitamin D. Furthermore, the increasing Vitamin D deficiency worldwide, along with the aging population, is driving the market growth for calcifediol in the form of supplements. Moreover, its use in treating secondary hyperparathyroidism, managing hypocalcemia, and preventing osteoporosis is leading to market expansion.

What are the Calcifediol Market Drivers?

• Rising Vitamin D deficiency, along with rising health awareness about micronutrient supplementation, will drive the calcifediol market growth

Globally, there is an increase in number of people with Vitamin D deficiency. The number of geriatric populations is also rising worldwide. The rising Vitamin D deficiency among the people, including the aged population, is creating demand for Vitamin D supplements. Calcifediol, a better alternative than other vitamin D, provides an effective solution to meet the demand for vitamin D in calcifediol supplements. Additionally, there is increasing health awareness among youth for their health and wellness. This has led to increased demand for micronutrients, resulting in a significant rise in the need for calcifediol supplements for vitamin D supplementation.

As per a study by the National Center of Biotechnology Information, 76.6% of participants had serum 25-hydroxyvitamin D deficiency below 75 nmol/l, showing a higher prevalence of deficiency of vitamin D. Globally, approx. 30-45% of people have vitamin D deficiency, making it around 1 billion.

• The livestock feed industry will be increasing the demand for calcifediol in the forecast period

The demand for calcifediol is increasing due to its usage in improving the health of livestock and the overall quality of feeds. Calcifediol is increasingly used to improve the health of livestock and poultry by enhancing bone strength, reproductive performance, immunity, and meat quality. It can improve vitamin D status as it is more easily absorbed than others.

As per Our World in Data Report, meat production worldwide has increased from 293.38 million tonnes in 2010 to 355.46 million tonnes in 2022. This increased production is expected to continue in the future as there is a need to feed the growing population, leading to a rise in demand for calcifediol for livestock and poultry.

Segment Analysis of the Calcifediol Market:

• By Application, Pharmaceuticals will be dominating the market of calcifediol.

Based on the application, calcifediol is segmented into pharmaceuticals, animal feed, and others. The pharmaceutical segment will be dominating the market for calcifediol in the forecast period.

Calcifediol is mostly used as a supplement for vitamin D deficiency or insufficiency and as a dietary supplement. It is also used as a liquid dose or capsule for treating diseases like refractory rickets, familial hypophosphatemia, osteoporosis, and secondary hypoparathyroidism, as it is a better alternative for improving vitamin D levels.  Thus, the calcifediol market will be primarily driven by the pharmaceutical industry, and this influence is expected to grow as its beneficial properties are being utilized more extensively in the future.

• North America would be the largest market shareholder for calcifediol in the forecast period.

Region-wise, the global market is segmented into Asia-Pacific, North America, South America, Europe, Middle East and Africa. In the forecast period, North America would hold the largest market share for Calcifediol.

There are increasing trends among people in North America, compared to other regions, for dietary supplements. With the prevalence of advanced healthcare infrastructure and significant innovations and advancement in the health sector, this region is poised for growth in the Calcifediol market. Additionally, North America is experiencing a demographic shift towards the older population. In the United States of America, there would be around 77 million people aged above 65 as per U.S. Census Bureau Project. Hence, North America will dominate this market in the forecast period.

Major Challenges in the Calcifediol Market:

• Limited awareness of Calcifediol and its properties is acting as a restraint for its market growth

Calcifediol is a better and more advanced alternative for Vitamin D deficiency as it offers faster and more efficient elevation in the body's vitamin D level than traditional vitamin D supplements like Vitamin D3 and Vitamin D2. Its absorption rate is higher than that of other forms of Vitamin D, which are used in pharma, yet the awareness of Calcifediol is limited when compared to other vitamin D supplements.

This limited awareness of Calcifediol as a Vitamin D supplement and for animal feed is restraining the market growth. Creating more awareness about the product and its advantages over traditional vitamin D supplements can effectively mitigate the restraint and lead to significant market growth of Calcifediol.

Key Developments in the Calcifediol Market:

• In May 2024, European union approved DSM-Firmenich’s ampli-D calcifediol supplement as a novel food. This would unlock new opportunities for market expansion in the European Union for DSM-Firmenich, a global innovator in nutrition, health, and beauty.

• In August 2022, Singapore-based firm MD Pharmaceuticals collaborated with DSM to develop a faster, faster-acting vitamin D supplement, branding it Rapid-D with Calcifediol.

• In January 2021, Australia’s Bioclinic and DSM partnered to launch ampli-D, a Vitamin D Supplement developed and manufactured by DSM. Bioclinic Naturals is the first supplement brand to launch a finished ampli-D product.